Regarding the safety profile of semaglutide 2.4 mg, the STEP programme highlighted an AE incidence ranging between 84.3% and 96.1% among treated participants, compared with 75.0%96.1% in placebo groups [13, 38,39,40,41,42,43,44,45,46]
It needs a physician who manages dose increases, side effects, and metabolic monitoring across the 5-step titration
Moreover, it boosts endothelial permeability by reducing the levels of Coll5a1, Lama4, and Sparc in the extracellular matrix and cytoskeleton [39]
Rest assured, you'll receive everything required for the process syringes, alcohol prep pads, and the medication itself
Not the best idea